Gene-Targeted Cancer Fix Could Be a Breakthrough
For first time in humans, scientists used RNA to stop production of protein driving malignancyContinue Reading
For first time in humans, scientists used RNA to stop production of protein driving malignancyContinue Reading
For lung cancer, studies to date have too many flaws, researchers sayContinue Reading
The nutrient could help those at genetic risk for the growths, study findsContinue Reading
Move includes near-elimination of cigarette vending machines, restrictions on advertisingContinue Reading
Simple measures could reduce high risks in certain populations, reports suggestContinue Reading
Suggestions for performing a self-examContinue Reading
Study in mice could lead to new treatments for smoking-related diseasesContinue Reading
Data on lesser known variants didn’t improve powers of standard risk modelContinue Reading
Rat studies suggest Victoza could spur rare thyroid tumor, but experts say effects in humans are unclearContinue Reading
Newspaper, magazine stories shy away from negative side effects, end-of-life care, review findsContinue Reading
3-year survival doubled after the treatment, study foundContinue Reading
Drug advances extend lives, but one study puts cost per life-year gained at about $66,200Continue Reading
Referrals to palliative care programs come too late, survey findsContinue Reading
Ten years later, many men weren’t bothered by treatment’s effects, study findsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.